Characteristics, treatment, and outcomes of Myasthenia Gravis in COVID-19 patients: A systematic review.

ABSTRACT:

Objective

Recent studies suggest that the clinical course and outcomes of patients with coronavirus disease 2019 (COVID-19) and myasthenia gravis (MG) are highly variable. We performed a systematic review of the relevant literature with a key aim to assess the outcomes of invasive ventilation, mortality, and hospital length of stay (HLoS) for patients presenting with MG and COVID-19.

Methods

We searched the PubMed, Scopus, Web of Science, and MedRxiv databases for original articles that reported patients with MG and COVID-19. We included all clinical studies that reported MG in patients with confirmed COVID-19 cases via RT-PCR tests. We collected data on patient background characteristics, symptoms, time between MG and COVID-19 diagnosis, MG and COVID-19 treatments, HLoS, an

SUBMITTER: Abbas AS 

PROVIDER: S-EPMC8782728 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature